MedTwenty News

Daily stories

One verified UK healthcare business story each weekday: what happened, why it matters and the source.

All subjects NHS & Healthcare Finance Healthcare Companies Healthcare Technology Regulation & Policy Investment & Markets

Everything Stories The Brief Analysis

All regions UK US Global

Two architectural models placed side by side on stone

Investment & Markets

Tempus acquires Personalis in $1.5bn deal, deepening push into cancer genomics

The AI-diagnostics firm absorbs its oncology genomics partner three years after their initial collaboration — and sets up a direct contest with Foundation Medicine for NHS pathology contracts. Full deal terms, adviser detail and competitive landscape analysis in the intelligence database.

LiveOruaro Onibere·4 min read·27 Sept 2026, 08:18

A circuit board resting on a stack of bound documents

Regulation & Policy

NHS fast-tracks AI deployment across services in bid to tackle waiting lists

A new national framework shortens procurement for triage, imaging and ambient documentation tools across integrated care systems.

LiveEditorial·3 min read·27 Sept 2026, 08:18

A vintage microphone beside a blank notepad on a desk

Healthcare Technology

Abridge raises $340m Series D to scale ambient AI across US health systems

Spark Capital leads the round as the ambient documentation category consolidates around a small number of enterprise vendors.

PremiumJ. Rodriguez·4 min read·27 Sept 2026, 07:30

A brass balance scale holding a stack of coins

Healthcare Companies

Medicare Advantage rate cuts reshape 2027 bids as plans retreat from rural markets

Plan filings show a measurable withdrawal from low-density counties as benchmark rates tighten for a third consecutive year.

PremiumM. Chen·5 min read·27 Sept 2026, 06:30

A white capsule on a ceramic plate beside an amber vial

Healthcare Technology

Merck secures first approval for an oral PCSK9 inhibitor, reshaping the cholesterol market

Lipfendra clears the FDA as the first oral entrant in a class previously limited to injectables, with a NICE appraisal pending.

PremiumS. Adeyemi·5 min read·27 Sept 2026, 02:30

An amber vial beside an empty glass petri dish

Healthcare Technology

FDA extends Casgevy approval to children aged two and over, raising payer coverage questions

The label extension widens the eligible population considerably while leaving outcome-based contracting unresolved.

R. Okonkwo·4 min read·26 Sept 2026, 08:30

An empty boardroom table with a closed folder

Healthcare Companies

Spire Healthcare appoints advisers as private hospital consolidation accelerates

The independent provider has retained advisers amid renewed interest in UK private hospital estates.

PremiumOruaro Onibere·3 min read·26 Sept 2026, 08:30

A microscope lens above a row of glass slides

Healthcare Technology

Paige raises $75m Series C to widen digital pathology footprint in Europe

The round funds regulatory work and NHS pathology network deployments through 2027.

J. Rodriguez·3 min read·25 Sept 2026, 08:30

A chess king standing beside a fallen pawn on stone

Investment & Markets

KKR completes Envision restructuring at $7.0bn, wiping out earlier equity

The restructuring closes one of the largest loss-making healthcare buyouts of the last decade.

PremiumM. Chen·6 min read·25 Sept 2026, 08:30

A fountain pen resting on a blank contract

Investment & Markets

Optum closes $3.2bn Landmark acquisition, extending home-based care reach

The transaction completes after a nine-month regulatory review.

M. Chen·4 min read·24 Sept 2026, 08:30

Showing 1–10 of 39 pieces